ABSTRACT
In this study, Fe3O4/hyperbranched polyester-(2-dodecen-1-yl)succinic anhydride2-Dodecen-1-/isoniazid magnetic nanoparticles (Fe3O4/HBPE-DDSA/INH MNPs) with controlled drug release characteristics were synthesized successfully by a simple one-step method. Orthogonal experiments were performed to optimize the loading capacity and encapsulation efficiency of the MNPs. The structure of the Fe3O4/HBPE-DDSA/INH MNPs was characterized by 1H nuclear magnetic resonance spectroscopy, matrix-assisted laser desorption/ionization mass spectrometry, Fourier transform infrared spectroscopy, X-ray diffraction analysis, transmission electron microscopy, and superconducting quantum interference device measurements, while their properties were characterized based on swelling behavior observations, in-vitro release experiments, and cytotoxicity analysis. The results indicated that the fabricated Fe3O4/HBPE-DDSA/INH MNPs had a high drug-loading capacity and encapsulation efficiency. Further, the drug-release rate of the MNPs was higher in an acidic buffer, indicating that the MNPs were pH-responsive. Swelling studies revealed that the MNPs exhibited diffusion-controlled drug release, while in-vitro release studies revealed that the drug-release properties could be controlled readily, owing to the high encapsulation efficiency of the MNPs and the uniform dispersion of the drug in them. These results collectively suggest that this multifunctional nontoxic drug delivery system, which exhibits good magnetic properties and pH-triggered drug-release characteristics, should be suitable for the treatment of tuberculosis.
Subject(s)
Ferrosoferric Oxide , Isoniazid , Nanoparticles/chemistry , Polyesters , Cell Line , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/pharmacokinetics , Delayed-Action Preparations/pharmacology , Ferrosoferric Oxide/chemistry , Ferrosoferric Oxide/pharmacokinetics , Ferrosoferric Oxide/pharmacology , Humans , Isoniazid/chemistry , Isoniazid/pharmacokinetics , Isoniazid/pharmacology , Polyesters/chemistry , Polyesters/pharmacokinetics , Polyesters/pharmacologyABSTRACT
In this paper, Fe3O4/chitosan/isoniazid magnetic nanoparticles (Fe3O4/CS/INH-MNPs) were prepared as an environmental stimuli-responsive drug-delivery system by automated in situ click technology, in which Fe3O4 magnetic nanoparticles, chitosan and isoniazid were simultaneously in situ crystallized by one-step method. The Fe3O4 magnetic nanoparticles and tripolyphosphate act as stable crosslinkers to produce numerous intermolecular crosslinkages for the mobility of the chitosan chains. Characterization results indicated that the multifunctional drug delivery system with optimized size, excellent loading capacity, well magnetic properties, nontoxicity and pH triggered drug release property is expected to be applied in tuberculosis treatment with excellent magnetic sensitivity and sustained release.
Subject(s)
Metal Nanoparticles , Chitosan , Drug Delivery Systems , Ferric Compounds , Humans , Isoniazid , TuberculosisABSTRACT
A novel biocompatible magnetic nanocomposite drug carrier was developed by first chemically modifying a hyperbranched polyester (HBPE) with dodecenyl succinic anhydride (DDSA) functional groups to produce HBPE-DDSA. The magnetic nanocomposite Fe3O4/HBPE-DDSA was then synthesized by dispersing superparamagnetic iron oxide (Fe3O4) nanoparticles within HBPE-DDSA. The structure and magnetic properties of the nanocomposite were characterized by 1H NMR, MALDI-MS, XRD, FTIR, TEM, and SQUID analyses. Isoniazid (INH) was selected as a model antituberculosis drug to investigate the in vitro drug release properties of Fe3O4/HBPE-DDSA/INH. The cytotoxicity of the magnetic nanocomposites was assessed by CCK-8 assay. The results indicated that Fe3O4/HBPE-DDSA is a promising potential drug carrier for a magnetic-targeted drug delivery system.
